Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Previously authors have recently described an association between nilotinib therapy for chronic myeloid leukemia (CML) and severe peripheral artery disease, coronary artery disease and sudden death. We present a case report of a male patient with CML who received nilotinib therapy. He developed bilateral renal artery stenosis and renovascular hypertension. He had no history of hypertension, cardiovascular disease, or diabetes, and he was a nonsmoker. Together, these observations indicated that obtaining further understanding of the effects is necessary and that extreme caution is warranted when considering second-generation tyrosine kinase inhibitors for first-line therapy in CML. © 2012 Elsevier Ltd.

Cite

CITATION STYLE

APA

Kristensen, T., Randers, E., & Stentoft, J. (2012). Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib. Leukemia Research Reports, 1(1), 1–3. https://doi.org/10.1016/j.lrr.2012.09.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free